- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04027062
Impact of Diabetes Continuing Education on Primary Health Care Physicians' Knowledge, Attitudes and Practice
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background:
Diabetes is one of the rapidly growing chronic health conditions across the world. Healthcare providers still continue to face difficulties in delivering optimal care and education worldwide. Thus, continuing education is needed to improve Knowledge, Attitudes and Practices of physicians.
Objective: To evaluate the effectiveness of a continuing education (CE) program on the Knowledge, Attitudes and Practices of primary health care physicians (HCPs) towards a high quality of diabetes care.
Design and Methods:
This is a quasi-experimental design composed of pre-test post-test uncontrolled experimental design. The study will include all PHC physicians registered in health sectors of Abha and Khamis Musheet cities, Aseer Region. The physicians will be invited to attend a CE program. All participants will fill out a questionnaire before and after the intervention. The change in knowledge and attitudes of the participants will be measured at the end of the program. After 4 months, the practice of physicians will be assessed through retrospective review of patient's files.
Impact:
Education programs could positively influence the knowledge, beliefs and attitudes of healthcare workers toward a high quality of diabetes care, which in turn plays a major role in improving clinical outcomes.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Hosam Y Almetahr, MBBS
- Phone Number: 966545919114
- Email: almetahr11@gmail.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- all PHC physicians registered in health sectors of Abha and Khamis musheet cities, Aseer Region
- willing to provide informed consent to participate in the study
Exclusion Criteria:
- physicians worked at hospital
- other health care professional (non-physicians)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Diabetes Continuing Education Program
the physicians will be assessed before and after intervention the intervention group will be enrolled to the intervention program proposed to be (lecture + interactive workshop + group discussion + role play) |
The program will follow the International Curriculum for Diabetes Health Professional Education, which developed by the International Diabetes Federation (IFD) The key components of the proposed program content are Diabetes presentation and complications, Lifestyle, Nutrition, and Fitness. the intervention will be carried out by group of Diabetes educators from a different discipline, such as an Endocrinologist, Family physician, the dietitian will teach the attended physicians. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percent of change of knowledge, attitude and practice of primary healthcare physicians
Time Frame: 4 months
|
the primary outcome will be the difference between pre- and post-intervention regarding knowledge, attitude and practice of primary healthcare physicians. the knowledge and attitude will be assessed by questionnaire while the practice will be assessed through a retrospective review of patient's files. |
4 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KingKalidU
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabete Mellitus
-
Rio Grande do Sul State Health Department - SES/RSAgnes Nogueira Gossenheimer; Ana Paula Rigo; Roberto Eduardo SchneidersNot yet recruitingTelemedicine | Diabete Mellitus | Diabete Type 2 | TelehealthBrazil
-
Hospices Civils de LyonCompletedDiabete Type 2 | Diabete Type 1France
-
Abbott Diabetes CareRecruiting
-
Abbott Diabetes CareCompleted
-
Rigshospitalet, DenmarkUniversity of Southern DenmarkUnknown
-
Abbott Diabetes CareCompleted
-
Medanta, The Medicity, IndiaRecruitingDiabete Mellitus | Liver Transplant; ComplicationsIndia
-
Seoul National University HospitalCompletedDiabete Mellitus | Pancreatectomy; Hyperglycemia
-
Kansaa A.IbrahimCompleted
Clinical Trials on Diabetes Continuing Education Intervention
-
Duke UniversityUniversity of Alabama at BirminghamCompleted
-
Pham Ngoc Thach University of MedicineEnrolling by invitation
-
Hospital de Clinicas de Porto AlegreFederal University of Rio Grande do SulCompleted
-
Huashan HospitalUnknown
-
Rabin Medical CenterCompleted
-
University of Colorado, DenverCompleted
-
University of PittsburghNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
University of North Carolina, Chapel HillCompletedEarly Childhood Dental CariesUnited States
-
University of AarhusDanish Cancer Society; TrygFonden, DenmarkWithdrawnChronic Obstructive Pulmonary Disease | Metastatic CancerDenmark
-
Carnegie Mellon UniversityCompletedType 2 DiabetesUnited States